References
- Arima, H., et al., 2008. High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study. Arteriosclerosis, thrombosis, and vascular biology, 28 (7), 1385–1391.
- Bertoni, A.G., et al., 2010. Inflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes care, 33 (4), 804–810.
- Cao, J.J., et al., 2003. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. Circulation, 108 (2), 166–170.
- Chen, P.C., et al., 2009. Metabolic syndrome and C-reactive protein in stroke prediction: a prospective study in Taiwan. Metabolism, 58 (6), 772–778.
- Chuang, C.H., et al., 2013. Homocysteine and C-reactive protein as useful surrogate markers for evaluating CKD risk in adults. Kidney & blood pressure research, 37 (4–5), 402–413.
- Chuang, H.H., et al., 2020. High-sensitivity C-reactive protein elevation is independently associated with subclinical renal impairment in the middle-aged and elderly population-A community-based study in Northern Taiwan. International journal of environmental research and public health, 17 (16), 5878.
- C Reactive Protein Coronary Heart Disease Genetics Collaboration. 2011. Association between C reactive protein and coronary heart disease: Mendelian randomisation analysis based on individual participant data. BMJ, 2011, 342.
- Danesh, J., 2000. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ, 321 (7255), 199–204.
- Doi, Y., et al., 2005. Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: the Hisayama Study. Diabetes care, 28 (10), 2497–2500.
- Flegal, K.M., et al., 1998. Overweight and obesity in the United States: prevalence and trends, 1960–1994. International journal of obesity and related metabolic disorders, 22 (1), 39–47.
- Fujita, K., et al., 2019. Obesity, inflammation, and prostate cancer. Journal of clinical medicine, 8 (2), 201.
- Furman, D., et al., 2019. Chronic inflammation in the etiology of disease across the life span. Nature medicine, 25 (12), 1822–1832.
- Hu, P., et al., 2013. IFLS C-reactive protein data user guide. RAND labor and population.
- International Physical Activity Questionnaire (IPAQ) Scoring Protocol., 2013. https://sites.google.com/site/theipaq/ [Accessed 27 October 2013].
- Iso, H., et al., 2012. The impact of C-reactive protein on risk of stroke, stroke subtypes, and ischemic heart disease in middle-aged Japanese: the Japan public health center-based study. Journal of atherosclerosis and thrombosis, 19, 756–766.
- Jiang, S., et al., 2009. Serum C-reactive protein and risk of cardiovascular events in middle-aged and older Chinese population. The American journal of cardiology, 103 (12), 1727–1731.
- Khera, A., et al., 2005. Race and gender differences in C-reactive protein levels. Journal of the american college of cardiology, 46 (3), 464–469.
- Koellinger, P.D., and de Vlaming, R., 2019. Mendelian randomization: the challenge of unobserved environmental confounds. International journal of epidemiology, 48 (3), 665–671.
- Liu, Y., et al., 2014. Relationship between C-reactive protein and stroke: a large prospective community based study. PLoS one, 9 (9), e107017.
- Masi, A.T., Aldag, J.C., and Sipes, J., 2001. Do elevated levels of serum C-reactive protein predict rheumatoid arthritis. Journal of rheumatology, 28, 2359–2361.
- Musunuru, K., et al., 2008. The use of high-sensitivity assays for C-reactive protein in clinical practice. Nature clinical practice. Cardiovascular medicine, 5 (10), 621–635.
- Nakanishi, S., et al., 2003. Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans. Diabetes care, 26 (10), 2754–2757.
- Nielen, M.M., et al., 2004. Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis. Arthritis & rheumatism, 50 (8), 2423–2427.
- Pearson, T.A., et al., 2003. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 107 (3), 499–511.
- Prins, B.P., et al., 2016. Investigating the causal relationship of C-reactive protein with 32 complex somatic and psychiatric outcomes: a large-scale cross-consortium mendelian randomization study. PLoS medicine, 13 (6), e1001976.
- Ridker, P.M., et al., 2000. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New England journal of medicine, 342 (12), 836–843.
- Ridker, P.M., 2003. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation, 107 (3), 363–369.
- Saito, I., et al., 2007. A low level of C-reactive protein in Japanese adults and its association with cardiovascular risk factors: the Japan NCVC-Collaborative Inflammation Cohort (JNIC) study. Atherosclerosis, 194 (1), 238–244.
- Saito, M., et al., 2003. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis, 167 (1), 73–79.
- Sinha, S., et al., 2014. hsCRP in pre-hypertension and hypertension: a prospective study in Southern Asian region. International journal of research in medical sciences, 2 (4), 1402–1407.
- Strauss, J., Witoelar, F., and Sikoki, B., 2016. The fifth wave of the Indonesia family life survey: overview and field report: Volume 1.
- Sung, K.C., et al., 2003. High sensitivity C-reactive protein as an independent risk factor for essential hypertension. American journal of hypertension, 16, 429–433.
- Vermeire, S., Van Assche, G., and Rutgeerts, P., 2006. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut, 55 (3), 426–431.
- Wakugawa, Y., et al., 2006. C-reactive protein and risk of first-ever ischemic and hemorrhagic stroke in a general Japanese population: the Hisayama Study. Stroke, 37 (1), 27–32.
- Wang, C., et al., 2013. Positive association between high-sensitivity C-reactive protein and incidence of type 2 diabetes mellitus in Japanese workers: 6-year follow-up. Diabetes/metabolism research and reviews, 29 (5), 398–405.
- WHO Expert Consultation. 2004. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet, 363, 157–163.
- Wilson, P.W., et al., 2008. C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study. Circulation: Cardiovascular quality and outcomes, 1 (2), 92–97.,
- Yamada, S., 2001. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population. American journal of epidemiology, 153 (12), 1183–1190.